Nanopatch Immunisation Against Pandemic Influenza: Improved Immune Responses At A Reduced Dose.
Funder
National Health and Medical Research Council
Funding Amount
$511,294.00
Summary
Development of a new way to vaccinate against influenza that will make standard vaccines 100 times more potent than conventional syringe injection. The Nanopatch is made from a silicon wafer, bristling with micro-nanoscale spikes. It painlessly deposits vaccine under the skin surface. Experiments in mice show that even a small vaccine payload delivered to the skin generates good immune responses. The Nanopatch vaccination system is expected to be ready for clinical trials within a few years.